US-based clinical research organization Parexel has announced the launch of its Community Alliance Network, a novel programme further integrating clinical research into the community healthcare setting to better serve patients and in turn create further opportunities for increased diversity in clinical trials.

CVS Health, the leading healthcare solutions company, and Javara, the leading integrated research organisation, have joined the network as inaugural members, opening the door to community-based research sites and increasing access to new patient populations to support trial delivery for Parexel’s biopharmaceutical customers. 

Over the last 10 years, Parexel has built its Site Alliance Network with more than 500 of the top clinical research institutions and 21,000 principal investigators across 20+ countries with diverse site staff and patient populations across all therapeutic areas. The company’s Community Alliance Network builds on these efforts through alliances with healthcare and research organizations that have close relationships with and proximity to patients who previously had no or little ability to participate in clinical research.